Articles

Over the last 30 years, the Premier League has become one of the biggest and most lucrative sports leagues in the world; putting the English game at the top of the football pyramid. One large driver of this success is the Premier League’s stance on innovation, and how maintaining an innovative attitude towards adoption of new technologies, broadcasting strategies and global marketing has taken the league from strength to strength.

So-called second medical use claims are a type of patent claim in the field of medicine. These claims are typically used to protect the use of a known substance or compound for a new and specific medical purpose. 

Quebec is Canada’s French speaking province, and as a general rule, products, commercial documents as well as public signs and commercial advertising in Quebec must abide by the Charter of the French Language (the “Charter”). At the administrative level, the Charter is enforced by the Office québécois de la langue française (the “OQLF”).

One morning during my undergraduate chemistry course I arrived at the organic chemistry teaching laboratory to be informed that today we would be synthesising N,N-diethyl-3-methylbenzamide, more commonly known as DEET, which is the most widely used active ingredient in commercial insect repellents. At the time, the significance of what I was making (or trying to make!) was lost on me.

In the latest Dead Cat Live Cat interview with Quantum specialists, host Phil Merchant, Principal at Marks & Clerk, interviews guest Vishal Shete, Managing Director at Terra Quantum UK.

The EU has introduced new legislation on AI, the EU AI Act, which lays the foundation for the regulation of, and responsible development of, AI across all industries within the EU.

Earlier this year the Indian Patent Office updated a number of rules to “address some of the major pain points experienced by the patent applicants in Indian patent procedure”. These include everyone’s favourite procedural requirements: filing annual working statements and periodically submitting the details and prosecution documents issued on corresponding foreign patent applications. Some of the key changes are summarised below.

Last Friday, 19th July 2024, the Court of Appeal handed down a highly anticipated decision in the case between the Comptroller General of Patents, Designs and Trade Marks (Comptroller) and Emotional Perception AI Ltd (EPL) [2024] EWCA Civ 825. This decision should provide greater clarity on the patentability in the UK of inventions using AI.

On 2 May 2024, the Paris Central Division of the UPC issued a decision concerning the jurisdiction and the applicability of the Brussels I Regulation (recast) in the context of a patent revocation action brought before the UPC. In the ongoing revocation action brought by Nokia Technology GmbH against Mala Technologies Ltd., a preliminary objection filed by Mala Technologies required the UPC to examine its relationship with the national courts of member states.